InMed Pharmaceuticals Inc. products

InMed’s subsidiary, BayMedica, has created an efficient, patent-pending, biological factory by taking the blueprints for cannabinoid biosynthesis from the cannabis plant and engineering it into ultra-efficient brewer’s yeast. BayMedica utilizes its expertise in synthetic chemistry to complement its biosynthesis platform. BayMedica’s platform has already shown that at scale its cannabinoids have both quality and cost advantages over cannabinoids produced via legacy agriculture.